| 000 | 01571 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513162433.0 | ||
| 264 | 0 | _c19990226 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0194-911X | ||
| 024 | 7 |
_a10.1161/01.hyp.33.1.312 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMüller, D N | |
| 245 | 0 | 0 |
_aEffects of human prorenin in rats transgenic for human angiotensinogen. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cJan 1999 |
||
| 300 |
_a312-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin I _xmetabolism |
| 650 | 0 | 4 |
_aAngiotensin II _xblood |
| 650 | 0 | 4 |
_aAngiotensinogen _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Genetically Modified |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aChemotherapy, Cancer, Regional Perfusion |
| 650 | 0 | 4 |
_aEnzyme Precursors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aRenin _xadministration & dosage |
| 700 | 1 | _aHilgers, K F | |
| 700 | 1 | _aMathews, S | |
| 700 | 1 | _aBreu, V | |
| 700 | 1 | _aFischli, W | |
| 700 | 1 | _aUhlmann, R | |
| 700 | 1 | _aLuft, F C | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 33 _gno. 1 Pt 2 _gp. 312-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.hyp.33.1.312 _zAvailable from publisher's website |
| 999 |
_c9892746 _d9892746 |
||